OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
about
Oligodendroglioma: pathology, molecular mechanisms and markersPrimary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor DabrafenibDifferential hypermethylation of death-associated protein kinase promoter in central neurocytoma and oligodendrogliomaAstrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment.OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.Ependymal tumors with oligodendroglioma like clear cells: Experience from a tertiary care hospital in PakistanCytoplasmic non-epithelial mucin accumulation associated with CD44 in an astrocytic tumor with signet ring features.Oligodendroglioma (WHO grade I) in a young epilepsy patient: a specific entity lying within the spectrum of dysembryoplastic neuroepithelial tumor?Leptomeningeal dissemination of a pediatric neoplasm with 1p19q deletion showing mixed immunohistochemical features of an oligodendroglioma and neurocytoma.Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.Findings from positron emission tomography and genetic analyses for cerebellar liponeurocytoma.Central neurocytoma with ependymoma-like glial component.Clear cell ependymoma: a mimicker of oligodendroglioma--report of three cases.Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.Papillary glioneuronal tumor
P2860
Q27002448-F70F7CD4-B542-4FB6-9339-91C12D5C9C21Q30389253-A7586008-7B0F-4444-9B53-5C3C993B8D19Q30412904-B4F6D915-9548-45BC-9E16-6CB4D9F555EDQ34185886-70B8DC41-44BB-41D3-B5EF-6821AA173387Q35179617-3F6EAA21-75E1-41E3-ABF7-D1603D630825Q36300721-734613D9-F425-4042-82BB-8839EE9DCFCBQ44218589-9A05FAB9-9715-4C0D-B627-79152FFE4871Q48152984-A98E5E2F-3618-4601-A235-A5171DBEA26EQ48210982-2AE39561-85C5-435D-A8AA-E821555B81FAQ48356097-5275BF07-9809-4069-85F9-CBC543BDFEDAQ48391103-8DEECED5-F5FB-49FE-B7DF-BA86D1815073Q48405190-FDB0DFEC-D41B-4495-B039-0814D6480872Q48473844-DD4ED5EC-5C14-4ED8-85F0-D3AADB7B3147Q50873479-8C9F30B1-1750-4737-8784-3CC168F79325Q55463689-BA31AB63-DA10-4E1D-BB90-6DE72873D4E2Q58003131-7371E2F2-7FE4-46A1-B01F-5C6183847E85
P2860
OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@ast
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@en
type
label
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@ast
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@en
prefLabel
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@ast
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@en
P2093
P2860
P1433
P1476
OLIG2 is a useful immunohistoc ...... ar cell primary CNS neoplasms.
@en
P2093
Hainfellner JA
Preusser M
P2860
P304
P356
10.1111/J.1365-2559.2007.02614.X
P577
2007-02-01T00:00:00Z